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Abstract
Carbazole is a class of phytochemical associated with cancer prevention. It attracted a significant interest in 
recent time for their usefulness in synthetic heterocyclic chemistry, analytical chemistry and pharmacology. The aim 
of the study was to evaluate the impact of biofield energy treatment on carbazole by various analytical methods. The 
study was performed in two groups i.e. control and treatment. The treatment group was subjected to Mr. Trivedi’s 
biofield treatment. Subsequently, both the samples were characterized with respect to physical and structural 
properties using X-ray diffraction (XRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), 
Fourier transform infrared (FT-IR), gas chromatography-mass spectrometry (GC-MS), laser particle size analyzer, 
and surface area analyzer. The XRD study revealed that the crystallite size of treated carbazole was decreased 
significantly with 37.5% as compared to the control. In addition, the intensity of XRD peaks was slightly decreased 
as compared to the control. The latent heat of fusion (ΔH) of treated carbazole was substantially increased by 
253.6% as compared to the control. Maximum degradation temperature (Tmax) of treated carbazole was increased 
by 41.46°C as compared to the control (211.93°C to 253.39°C). FT-IR spectra showed similar stretching frequencies 
in both control and treated carbazole samples. GC-MS data revealed that isotopic abundance ratio of either 13C/12C 
or 15N/14N or 2H/1H (PM+1/PM) of treated carbazole was significantly increased up to 278.59%. Particle size analysis 
showed substantial decrease in average particle size (d50) and d90 of the treated carbazole by 25.24% and 4.31%, 
respectively as compared to the control. The surface area analysis exhibited an increase in the surface area of 
treated sample by 4.8% as compared to the control. Overall, the experimental results suggest that biofield energy 
treatment has significant effect on physical, spectral and thermal properties of carbazole.
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Introduction
Carbazole is a nitrogen containing heterocycle, which was found in 
nature as alkaloids and in crude oils (0.3%). Out of 0.3% in crude oil, 
a major fraction, about 70-75% is comprised of heterocycles, carbazole 
and indole [1]. The preliminary research had conducted by Stanford 
Medicine, they conclude that the compounds present in food called 
phytochemicals; (carbazole and indole class of phytochemicals) which 
can decrease the risk of developing diseases such as hypertension, 
diabetes, and cancer [2]. Carbazole and indole have received significant 
attention in compounds which are active against cancer, and 
cardiovascular disorders [3,4], that exhibit antioxidant, antidiabetic, 
antimitotic, and antimicrobial activities [5-8]. Furthermore, carbazole 
derivatives also play a significant role as an active material in the 
organic light emitting diodes for blue light emission and organic 
field-effect transistors (OFET) [9,10]. Due to their wide range of 
synthetic applications, in the development of pharmaceutical and 
organic semiconductors, chemical or physical stability is the main 
concern and utmost criteria. The stability could be enhanced by Mr. 
Trivedi’s biofield energy treatment which is already known to alter 
the physical, and structural properties of various living and non-living 
substances [11]. The biofield, which surrounds the human body, and 
can be harnessed from the Universe. It has been applied on materials by 
experts in a controlled way to make the changes [12]. This phenomenon 
is experimentally demonstrated by researchers and biofield can be 
measured using medical technologies such as electromyography, 
electrocardiography, and electroencephalogram [13]. National 
Center for Complementary and Alternative Medicine (NCCAM) has 
recommended the uses of alternative Complementary and Alternative 
Medicine (CAM) therapies in the healthcare sector and about 36% of 
Americans regularly use some form of CAM [14]. Mr. Trivedi has the 
ability to harness the energy from the universe and can transmit the 
energy into any object, living or nonliving things [15]. Mr. Trivedi’s 
unique biofield treatment is also known as The Trivedi Effect® which 
has been applied in various research fields including microbiology 
research [17], agriculture research [18], and biotechnology research 
[19]. Thus, in this study, Mr. Trivedi’s biofield energy treatment was 
applied on carbazole to see the impact with respect to their physical, 
thermal and spectral properties. 
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simultaneous thermogravimetric analyzer at a heating rate of 5ºC/min 
from room temperature to 400ºC under air atmosphere. 
FT-IR spectroscopic characterization
FT-IR characterization was done with Shimadzu Fourier transform 
infrared spectrometer (Japan) with frequency range of 500-4000 cm-1. 
Carbazole was run as pressed disks using KBr as the diluent.
GC-MS analysis 
The gas chromatography-mass spectrometry (GC-MS) analysis 
was performed on Perkin Elmer/auto system XL with Turbo Mass, 
USA, having detection limit up to 1 picogram. The GC-MS data was 
obtained in the form of % abundance vs. mass to charge ratio (m/z), 
which is known as mass spectrum. The isotopic ratio of PM+1/PM 
was expressed by its deviation in treated samples as compared to the 
control. 
Particle size analysis
Particle size distribution of control and treated samples were 
analyzed by using Sympetac Helos-BF laser particle size analyzer with 
a detection range of 0.1 to 875 µm. Average particle size d50 and d99 
(size exhibited by 99% of powder particles) were computed from laser 
diffraction data table. 
Surface area analysis 
The surface area was measured by Smart SORB 90, the Brunauer–
Emmett–Teller (BET) surface area analyzer. 
Results and Discussion 
X-ray diffraction studies 
XRD study was conducted on both control and treated samples 
of carbazole and diffractograms are shown in Figure 1. Both control 
and treated carbazole samples exhibited very sharp and intense 
peaks of intensity 6200 a.u. and 4900 a.u., in their respective X-ray 
diffractograms. The control carbazole exhibited the XRD peaks at 2θ 
equal to 18.52, 27.95, 36.4, 37.6, 47.01, and 47.49. However, the XRD 
diffractogram of treated carbazole showed the XRD peaks at 2θ equal 
to 18.49, 27.89, 27.99, 37.49, 37.61, and 47, with decreased intensity 
Experimental
Materials 
Carbazole was procured from Sisco Research Laboratories (SRL), 
India. 
Biofield energy treatment modalities 
Carbazole was taken in this experiment for biofield energy 
treatment. The compound was divided into two parts named as control 
and treated. No treatment was given to the control set. The treated 
group was handed over to Mr. Trivedi for biofield energy treatment 
in sealed pack under standard laboratory conditions. Mr. Trivedi 
provided the treatment through his energy transmission process to 
the treated group without touching the sample. After treatment, the 
treated samples were stored at standard laboratory conditions for GC-
MS analysis as per the standard operating protocol. The control and 
treated samples were characterized using Gas chromatography-mass 
spectrometry (GC-MS). The experimental results in treated groups 
were analyzed and compared with the control set.
Percent changes in treated sample with respect to control were 
calculated using the following equation:
%Change = [Treated-Control]/Control×100
X-ray diffraction (XRD) study
XRD analysis of carbazole was carried out on Phillips, Holland 
PW 1710 X-ray diffractometer system, with radiation of wavelength 
1.54056 Å. The crystallite size (G) was calculated by using formula: G = 
kλ/(bCosθ). Here, λ is the wavelength of radiation, b is full-width half 
maximum (FWHM) of peaks and k is the equipment constant (=0.94). 
Differential scanning calorimetry (DSC) study 
The DSC thermogram of carbazole was acquired by using Perkin 
Elmer/Pyris-1, USA at flow rate of 5 mL/min using closed aluminum 
pan. Melting temperature and latent heat of fusion were obtained from 
the DSC curve. 
Thermogravimetric analysis (TGA)/ derivative 
thermogravimetry (DTG)
TGA/DTG results were obtained by using Mettler Toledo 
Figure 1: X-ray diffractograms of control and treated samples of carbazole.
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as compared to the control (Table 1). Literature report showed that 
the single crystals of carbazole are orthorhombic with four molecules 
in a unit cell [20]. The crystallite size was calculated using Scherrer 
formulae and found decreased after biofield treatment by 37.50% in 
the treated carbazole [21]. Moreover, it was reported that crystallite 
size and surface area are inversely proportional to each other [22]. 
The solubility profile of carbazole may alter after biofield treatment, as 
the crystallite size of the compound decreased which may increase the 
surface area and hence increase the solubility. 
DSC analysis
The DSC curve of control and treated samples of carbazole are 
shown in Figure 2. The latent heat of fusion (ΔH) was increased in 
the treated carbazole from 56.22 to 198.60 J/g (~253%). It might be 
possible that biofield energy favoring a strong π-π interaction of 
carbazole moiety in solid state. As the hydrogen bond such as N-H…N 
is not possible to form in the crystal due to the position (H atom is 
on the plane of the molecule) and hybridization of N atom [20]. A 
higher melting point was observed in the treated carbazole (247.53 oC) 
as compared to the control sample (245.54 oC), (Table 2). This result 
showed that treated carbazole sample needed more energy in the form 
of ΔH to undergo the process of melting at a higher temperature. It is 
hypothesized that the biofield energy might increase the intermolecular 
force in treated carbazole molecules, which possibly increase the 
melting point and latent heat of fusion.
TGA/DTG analysis
The TGA thermogram of both control and treated samples of 
carbazole are shown in Figure 3(a) and 3(b), respectively. TGA curve 
showed that the control and treated samples were degraded in two steps. 
For first step degradation, in control sample, the onset temperature was 
at 179.72°C and endset at 230°C. However, in treated sample, onset 
temperature was observed at 224.18°C and endset at 275.55°C. In this 
process, the control sample lost 29.6% of its initial weight, whereas 
treated sample lost 44.20% of its initial weight. For the second step 
degradation, in control sample, the onset temperature was found at 
258°C and endset at 336°C, while treated sample showed the onset at 
282.59°C and endset at 308.75°C. In this process, control sample lost 
its weight of 57.46%, whereas treated sample lost 1.14% of its initial 
weight. The DTG thermogram showed the Tmax corresponding to first 
and second step degradation as 211.93°C and 298.91°C, respectively 
in control, which was changed to 253.39°C and 295.50°C, respectively 
in treated sample. It indicated that Tmax for the first step was increased 
in treated sample as compared to the control. Thus, the increase in 
melting temperature and maximum degradation temperature of treated 
carbazole can be related to increase in thermal stability. The overall 
increases in thermal stability of treated sample might be advantageous 
to be used as a core moiety (pharmacophore) in medicine and synthetic 
conducting polymers. 
FT-IR spectroscopic analysis
FTIR spectra of control and treated samples of carbazole are 
presented in Figure 4. The FTIR spectra showed the secondary amine 
N-H stretching frequency at 3419 cm-1 for control and treated samples of 
carbazole. The IR spectra of both control and treated carbazole samples 
showed C-N stretching at 1450 cm-1 and out of plane NH bending at 
727 cm-1. Furthermore, the C-H deformation bends were assigned to 
the peaks at 1327 cm-1 in both control and treated samples of carbazole. 
The C-H aromatic stretching frequency was observed at 3051 cm-1 for 
both control and treated samples of carbazole. N-C aromatic stretching 
frequency was observed at 1327 cm-1 in both the control and treated 
samples of carbazole. The spectra indicated that there was no alteration 
in the hydrogen bonding environment in both treated and control 
samples of carbazole. The FT-IR results did not show any major shift of 
frequencies in both aromatic and functional group region (N-H, N-C, 
and C-H stretching frequency). The FTIR spectral data is well matched 
with the literature data [23].
GC-MS spectrometry 
The treated sample of carbazole was divided into four parts as T1, 
T2, T3, and T4. The mass spectrum of control and treated samples of 
carbazole are shown in Figure 5(a) and 5(b). Mass spectra showed the 
PM (primary molecule) peak at m/z = 167 in control and all the treated 
Carbazole 2θ FWHM of peak intensity 100%
Crystallite 
size
‘G’ x 10-9 m
Percent 
change in 
‘G’ wrt 
control
 Control 18.52, 27.95, 36.4, 37.6, 47.01, 47.49 0.12 85.83
Treated 18.49, 27.89, 27.99, 37.49, 37.61, 47 0.18 52.40 -37.50
FWHM: full width half maximum, wrt: with respect to.
Table 1: XRD analysis of control and treated carbazole.
Figure 2: DSC plots of control and treated carbazole.
Parameter Carbazole
Latent heat of fusion ΔH (J/G)
Control Treated
56.22 198.60
Melting point (ºC) 245.54 247.53
Table 2: DSC analysis of control and treated carbazole.
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samples of carbazole. The intensity ratio of PM+1 (i.e. m/z = 168) and 
PM (i.e. m/z = 167) peaks are presented in Table 3. There were three 
major peaks observed in control sample i.e. at m/z = 167, 139 and 84 due 
to carbazole and its degraded products. The degradation of carbazole, 
corresponded to the following ions: C10H5N+ and C5H10N+ respectively, 
were well matched with the previously reported GC-MS data [24]. The 
treated carbazole samples (T1-T4) were fragmented in a different way 
as compared to the control. For instance, peaks at m/z = 113, 63, 39, 
and 28 were observed in T1 to T4 due to PM fragmentation of treated 
carbazole to C7H15N+, C5H3+ C3H3+ and C2H2+ radicals respectively. 
Isotopic abundance ratio of 13C/12C or 15N/14N or 2H/1H (PM+1)/PM in 
carbazole was calculated and presented in Figure 6. It showed that the 
isotopic ratio of (PM+1)/PM in carbazole was significantly increased 
by 278.59% in sample T4, while it was decreased by 26.26% in treated, 
T1 sample as compared to the control. The biofield treatment may 
have altered the isotopic abundance ratio of (PM+1)/PM of treated 
carbazole from the control sample. Furthermore, it is assumed that 
higher isotopic ratio of (PM+1)/PM, might have increased the stability 
of the compound due to the increased µ (reduced mass) and binding 
energy in molecules in heavier isotopic compound. This higher binding 
energy may lead to increase the bond strength for treated carbazole 
and reverse might happen in treated T1 [25]. Thus, GC-MS data 
suggested that biofield treatment has significantly altered the isotopic 
ratio of 13C/12C or 15N/14N or 2H/1H (PM+1)/PM to 278.59%, in treated 
carbazole molecule. The lattice parameters of two chemically identical 
crystals formed by different isotopes do not correspond to the same 
value which may be reflected in the increased melting and degradation 
temperature of the treated molecule [26,27].
Particle size analysis
The particle size of control and treated carbazole is computed from 
the particle size distribution graph. The average particle size of d50 and 
Figure 3a: TGA thermogram of control sample of carbazole.
Figure 3b: TGA thermogram of treated sample of carbazole.
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d90 of the particles are shown in Table 4. The d50 of control carbazole 
was 287.71 µm and it was decreased substantially to 215.08 µm in the 
treated sample. Whereas, the d90 of the control sample was 535.23 µm 
and it was decreased to 512.12 µm in treated sample. The result showed 
significant decrease in d50 and d90 by 25.24 and 4.31%, respectively 
in the treated carbazole with respect to control sample. This distinct 
reduction in particle size of treated compound due to the biofield 
energy treatment and it is supported by decrease in crystallite size in 
the XRD results. It is assumed that the energy treatment might fracture 
the internal boundaries of particles and that may result into smaller 
particle size [28].
Surface area analysis
The surface area analysis was conducted using BET method and 
results are presented in Figure 7. The control sample showed a surface 
area of 0.46 m2/g and it was increased to 0.48 m2/g in treated samples of 
carbazole. The result showed increase in surface area of treated sample 
by 4.80% with respect to the control. Crystallite size and particle size 
are inversely proportional to the surface area of the compound. Thus, 
the decrease in particle size led to increase the surface area of treated 
sample.
Conclusions
In summary, the crystallite size was significantly decreased by 
37.50% in treated carbazole as compared to the control. In addition, the 
decrease in the intensity of the diffractogram in treated samples may be 
due to the decrease in crystallinity. The melting point and latent heat 
of fusion were substantially increased by ~2oC and 142 J/g, respectively 
Figure 4: FT-IR spectra of control and treated samples of carbazole.
Figure 5a: GC-Mass spectrum of control sample of carbazole.
Figure 5b: GC-MS spectra of treated (T1, T2, T3 and T4) samples of 
carbazole.
Parameter Control Treated
T1 T2 T3 T4
Peak Intensity at m/z= (PM) 100 100 100 100 100
Peak Intensity at m/z= (PM+1) 18.36 13.54 22.70 12.81 69.51
Percent Change of Isotopic 
abundance in (PM+1)/PM -26.25 23.63 -30.22 278.59
Table 3: GC-MS isotopic abundance analysis result of carbazole.
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in treated samples as compared to the control. Moreover, maximum 
degradation temperature (Tmax) was increased by 41.46°C that indicated 
the enhanced thermal stability of the biofield treated carbazole. The 
GC-MS data revealed that isotopic abundance ratio of 13C/12C or 
15N/14N or 2H/1H (PM+1)/PM of treated carbazole was significantly 
increased up to 278.59% of T4 sample as compared to the control. It is 
assumed that due to high isotopic abundance ratio of (PM+1)/PM of 
treated (T4) carbazole, with higher binding energy may lead to higher 
chemical stability than the control. This is well corroborated with the 
particle size and surface area analysis of the carbazole sample. It is 
assumed that the enhancement in thermal stability of carbazole could 
be more useful as a building block in various pharmaceutical products 
and conducting polymers which ultimately affect the shelf-life and 
efficacy of the product.
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Figure 7: Surface area analysis of control and treated carbazole sample.
Particle Size Control (µm) Treated (µm)
d50 287.71 215.08
d90 535.23 512.12
Table 4: The average particle size of control and treated carbazole.
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